Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis

Arthritis Care and Research

Volumn 59, Issue 4, 2008, Pages 504-509

  Thombs, Brett D ^a   Hudson, Marie ^a   Taillefer, Suzanne S ^a   Baron, Murray ^a   Markland, J ^b   Pope, J ^b   Robinson, D ^b   Jones, N ^b   Docherty, P ^b   Abu Hakima, M ^b   LeClercq, S ^b   Khalidi, N A ^b   Kaminska, E ^b   Sutton, E ^b   Smith, C D ^b   Mathieu, J P ^b   Ligier, S ^b   Rahman, P ^b  

^a MCGILL UNIVERSITY   (Canada)

^b Institute of Community and Family Psychiatry ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; DEMOGRAPHY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; EDUCATIONAL STATUS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL EXAMINATION; PREVALENCE; RATING SCALE; SOCIOECONOMICS; SYMPTOMATOLOGY; SYSTEMIC SCLEROSIS;

CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SCLERODERMA, SYSTEMIC;

EID: 42449155963     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23524     Document Type: Article

References (36)

1. Seibold J. Scleroderma. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, et al, editors. Kelley's textbook of rheumatology. 7th ed. Philadelphia: Elsevier; 2005. p. 1279-308.
2. Wigley FM, Hummers LK. Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weismann WH, editors. Rheumatology. 3rd ed. Philadelphia: Mosby; 2003. p. 1463-80.
3. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
4. Haythornthwaite JA, Heinberg LJ, McGuire L. Psychologic factors in scleroderma. Rheum Dis Clin North Am 2003;29:427-39.
5. Richards HL, Herrick AL, Griffin K, Gwilliam PD, Loukes J, Fortune DG. Systemic sclerosis: patients' perceptions of their condition. Arthritis Rheum 2003;49:689-96.
6. Lundborg CN, Nitescu PV, Appelgren LK, Curelaru ID. Progressive systemic sclerosis: intrathecal pain management. Reg Anesth Pain Med 1999;24:89-93.
7. Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM, et al. Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol 2003;22:130-9.
8. Thombs BD, Haines JM, Bresnick MG, Magyar-Russell G, Fauerbach JA, Spence RJ. Depression in burn reconstruction patients: symptom prevalence and association with body image dissatisfaction and physical function. Gen Hosp Psychiatry 2007;29:14-20.
9. Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 2007;57:1089-97.
10. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
11. Clements PJ, Seibold JR, Furst DE, Mayes M, White B, Wigley F, et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum 2004;33:249-63.
12. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
13. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
14. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
15. Cohen J, Cohen P, West SG, Aiken LS. Applied multiple regression/correlation analysis for the behavioral sciences, 3rd ed. Mahwah (NJ): Lawrence Erlbaum; 2003.
16. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005;32:51-7.
17. Beck AT, Steer RA, Beck Depression Inventory manual. San Antonio (TX): Psychological Corporation; 1993.
18. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
19. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006;21:30-8.
20. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, Boling C, Reed J, White B, et al. The impact of pain and symptoms of depression in scleroderma. Pain 2002;95:267-75.
21. Roca RP, Wigley FM, White B. Depressive symptoms associated with scleroderma. Arthritis Rheum 1996;39:1035-40,
22. Beretta L, Astori S, Ferrario E, Caronni M, Raimondi M, Scorza R. Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo 2006;58:219-25. In Italian.
23. Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada S, et al. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 2003;30:1782-7.
24. Richards H, Herrick A, Griffin K, Gwilliam P, Fortune D. Psychological adjustment to systemic sclerosis: exploring the association of disease factors, functional ability, body related attitudes and fear of negative evaluation. Psychol Health Med 2004;9:29-39.
25. Van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002;57:412-6.
26. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol 1999;84:348-50.
27. Lesman-Leegte I, Jaarsma T, Sanderman R, Linssen G, van Veldhuisen DJ. Depressive symptoms are prominent among elderly hospitalised heart failure patients. Eur J Heart Fail 2006;8:634-40.
28. Skotzko CE, Krichten C, Zietowski G, Alves L, Freudenberger R, Robinson S, et al. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail 2000;6:300-5.
29. Covic T, Tyson G, Spencer D, Howe G. Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictors. J Psychosom Res 2006;60:469-76.
30. Johnson SR, Glaman DD, Schentag CT, Lee P. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol 2006;33:1117-22.
31. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, et al, for the Scleroderma Lung Study Group. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum 2005;52:592-600.
32. Thompson A, Kent G. Adjusting to disfigurement: processes involved in dealing with being visibly different. Clin Psychol Rev 2001;21:663-82.
33. Lawrence JW, Fauerbach JA, Thombs BD. A test of the moderating role of importance of appearance in the relationship between perceived scar severity and body-esteem among adult burn survivors. Body Image 2006;3:101-11.
34. Beck AT. Depression: causes and treatment. Philadelphia: University of Pennsylvania; 1967.
35. Blalock SJ, DeVellis RF, Brown GK, Wallston KA. Validity of the Center for Epidemiological Studies Depression Scale in arthritis populations. Arthritis Rheum 1989;32:991-7.
36. Callahan LF, Kaplan MR, Pincus T. The Beck Depression Inventory, Center for Epidemiological Studies Depression Scale (CES-D), and General Well-Being Schedule depression subscale in rheumatoid arthritis: criterion contamination of responses. Arthritis Care Res 1991;4:3-11.